203 related articles for article (PubMed ID: 19836752)
21. Advanced QSRR modeling of peptides behavior in RPLC.
Bodzioch K; Durand A; Kaliszan R; Baczek T; Vander Heyden Y
Talanta; 2010 Jun; 81(4-5):1711-8. PubMed ID: 20441962
[TBL] [Abstract][Full Text] [Related]
22. A high dimensional QSAR study on the aldose reductase inhibitory activity of some flavones: topological descriptors in modeling the activity.
Prabhakar YS; Gupta MK; Roy N; Venkateswarlu Y
J Chem Inf Model; 2006; 46(1):86-92. PubMed ID: 16426043
[TBL] [Abstract][Full Text] [Related]
23. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
[TBL] [Abstract][Full Text] [Related]
24. Hair analysis of anabolic steroids in connection with doping control-results from horse samples.
Anielski P
J Mass Spectrom; 2008 Jul; 43(7):1001-8. PubMed ID: 18563854
[TBL] [Abstract][Full Text] [Related]
25. Review on modelling aspects in reversed-phase liquid chromatographic quantitative structure-retention relationships.
Put R; Vander Heyden Y
Anal Chim Acta; 2007 Oct; 602(2):164-72. PubMed ID: 17933600
[TBL] [Abstract][Full Text] [Related]
26. Modeling calcium channel antagonistic activity of dihydropyridine derivatives using QTMS indices analyzed by GA-PLS and PC-GA-PLS.
Mohajeri A; Hemmateenejad B; Mehdipour A; Miri R
J Mol Graph Model; 2008 Apr; 26(7):1057-65. PubMed ID: 17959402
[TBL] [Abstract][Full Text] [Related]
27. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
28. Analysis of anabolic steroids in hair by GC/MS/MS.
Gambelunghe C; Sommavilla M; Ferranti C; Rossi R; Aroni K; Manes N; Bacci M
Biomed Chromatogr; 2007 Apr; 21(4):369-75. PubMed ID: 17294499
[TBL] [Abstract][Full Text] [Related]
29. Nutritional supplements cross-contaminated and faked with doping substances.
Geyer H; Parr MK; Koehler K; Mareck U; Schänzer W; Thevis M
J Mass Spectrom; 2008 Jul; 43(7):892-902. PubMed ID: 18563865
[TBL] [Abstract][Full Text] [Related]
30. Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis.
Pozo OJ; De Brabanter N; Fabregat A; Segura J; Ventura R; Van Eenoo P; Deventer K
Bioanalysis; 2013 Nov; 5(21):2661-77. PubMed ID: 24180506
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions.
Wang C; Skibic MJ; Higgs RE; Watson IA; Bui H; Wang J; Cintron JM
J Chromatogr A; 2009 Jun; 1216(25):5030-8. PubMed ID: 19439313
[TBL] [Abstract][Full Text] [Related]
32. Application of fast gas chromatography/mass spectrometry for the rapid screening of synthetic anabolic steroids and other drugs in anti-doping analysis.
Mazzarino M; Orengia M; Botrè F
Rapid Commun Mass Spectrom; 2007; 21(24):4117-24. PubMed ID: 18022961
[TBL] [Abstract][Full Text] [Related]
33. Detection of anabolic steroid abuse using a yeast transactivation system.
Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
[TBL] [Abstract][Full Text] [Related]
34. Prediction of retention indices for identification of fatty acid methyl esters.
Farkas O; Zenkevich IG; Stout F; Kalivas JH; Héberger K
J Chromatogr A; 2008 Jul; 1198-1199():188-95. PubMed ID: 18533170
[TBL] [Abstract][Full Text] [Related]
35. Prediction of toxicity of nitrobenzenes using ab initio and least squares support vector machines.
Niazi A; Jameh-Bozorghi S; Nori-Shargh D
J Hazard Mater; 2008 Mar; 151(2-3):603-9. PubMed ID: 17630186
[TBL] [Abstract][Full Text] [Related]
36. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
McKinney AR
Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
[TBL] [Abstract][Full Text] [Related]
37. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
38. Classification of high-speed gas chromatography-mass spectrometry data by principal component analysis coupled with piecewise alignment and feature selection.
Watson NE; Vanwingerden MM; Pierce KM; Wright BW; Synovec RE
J Chromatogr A; 2006 Sep; 1129(1):111-8. PubMed ID: 16860329
[TBL] [Abstract][Full Text] [Related]
39. Quantitative structure-retention relationships for gas chromatographic retention indices of alkylbenzenes with molecular graph descriptors.
Ivanciuc O; Ivanciuc T; Klein DJ; Seitz WA; Balaban AT
SAR QSAR Environ Res; 2001 Feb; 11(5-6):419-52. PubMed ID: 11328713
[TBL] [Abstract][Full Text] [Related]
40. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine.
Fragkaki AG; Angelis YS; Tsantili-Kakoulidou A; Koupparis M; Georgakopoulos C
J Steroid Biochem Mol Biol; 2009 May; 115(1-2):44-61. PubMed ID: 19429460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
